ROYAL BANK OF CANADA - SUMMIT THERAPEUTICS PLC ownership

SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 14 filers reported holding SUMMIT THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SUMMIT THERAPEUTICS PLC
ValueSharesWeighting
Q3 2018$24,000
-17.2%
11,000
-7.6%
0.00%
Q2 2018$29,000
-81.2%
11,9000.0%0.00%
Q1 2018$154,000
+450.0%
11,900
+376.0%
0.00%
Q4 2017$28,000
-9.7%
2,5000.0%0.00%
Q3 2017$31,000
+10.7%
2,5000.0%0.00%
Q2 2017$28,0002,5000.00%
Other shareholders
SUMMIT THERAPEUTICS PLC shareholders Q4 2018
NameSharesValueWeighting ↓
LANSDOWNE PARTNERS (UK) LLP 2,667,350$7,922,0000.33%
Polar Capital LLP 4,500,000$13,365,0000.12%
Inscription Capital, LLC 17,000$50,0000.03%
BBR PARTNERS, LLC 50,000$149,0000.02%
Checchi Capital Advisers, LLC 20,000$59,0000.01%
Cornerstone Investment Partners, LLC 34,825$103,0000.01%
ACADIAN ASSET MANAGEMENT LLC 49,257$146,0000.00%
Renaissance Technologies 361,112$1,073,0000.00%
HSBC HOLDINGS PLC 150,975$448,0000.00%
CAPTRUST FINANCIAL ADVISORS 11,000$35,0000.00%
View complete list of SUMMIT THERAPEUTICS PLC shareholders